Abound Wealth Management Arrowhead Pharmaceuticals, Inc. Transaction History
Abound Wealth Management
- $354 Billion
- Q2 2025
A detailed history of Abound Wealth Management transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Abound Wealth Management holds 8 shares of ARWR stock, worth $125. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8
Previous 8
-0.0%
Holding current value
$125
Previous $102,000
24.51%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ARWR
# of Institutions
295Shares Held
97.8MCall Options Held
306KPut Options Held
432K-
Black Rock Inc. New York, NY15.7MShares$246 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.2MShares$207 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$174 Million2.29% of portfolio
-
State Street Corp Boston, MA7MShares$110 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY5.23MShares$82.1 Million1.32% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $1.66B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...